5 research outputs found
Die Empfehlungen der Swiss Memory Clinics für die Diagnostik der Demenzerkrankungen [Recommendations of Swiss Memory Clinics for the Diagnosis of Dementia]
The early diagnosis of subjectively perceived or externally anamnestically observed cognitive impairments is essential
for proving neurodegenerative diseases or excluding treatable causes such as internal, neurological or psychiatric
disorders. Only in this way is early treatment made possible. As part of the project 3.1 of the National Dementia Strategy
2014–2019 («Development and expansion of regional and networked centres of competence for diagnostics»), the association
Swiss Memory Clinics (SMC) set itself the goal of developing quality standards for dementia clarification and improving
the community-based care in this field. In these recommendations, general guidelines of diagnostics and individual
examination possibilities are presented, and standards for the related processes are suggested. Individual areas such as
anamnesis, clinical examination, laboratory examination, neuropsychological testing and neuroradiological procedures are
discussed in detail as part of standard diagnostics, and supplementary examination methods for differential diagnosis
considerations are portrayed. The most important goals of the SMC recommendations for the diagnosis of dementia are to
give all those affected access to high-quality diagnostics, if possible, to improve early diagnosis of dementia and to offer
the basic service providers and the employees of Memory Clinics a useful instrument for the clarification
Recommandations de Swiss Memory Clinics pour le diagnostic des démences [Recommendations of Swiss Memory Clinics for the Diagnosis of Dementia]
Recommendations of Swiss Memory Clinics for the Diagnosis of Dementia Abstract. The early diagnosis of subjectively perceived or externally anamnestically observed cognitive impairments is essential for proving neurodegenerative diseases or excluding treatable causes such as internal, neurological or psychiatric disorders. Only in this way is early treatment made possible. As part of the project 3.1 of the National Dementia Strategy 2014-2019 ('Development and expansion of regional and networked centres of competence for diagnostics'), the association Swiss Memory Clinics (SMC) set itself the goal of developing quality standards for dementia clarification and improving the community-based care in this field. In these recommendations, general guidelines of diagnostics and individual examination possibilities are presented, and standards for the related processes are suggested. Individual areas such as anamnesis, clinical examination, laboratory examination, neuropsychological testing and neuroradiological procedures are discussed in detail as part of standard diagnostics, and supplementary examination methods for differential diagnosis considerations are portrayed. The most important goals of the SMC recommendations for the diagnosis of dementia are to give all those affected access to high-quality diagnostics, if possible, to improve early diagnosis of dementia and to offer the basic service providers and the employees of Memory Clinics a useful instrument for the clarification
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies.
The lifetime prevalence of panic disorder (PD) is up to 4% worldwide and there is substantial evidence that genetic factors contribute to the development of PD. Single-nucleotide polymorphisms (SNPs) in TMEM132D, identified in a whole-genome association study (GWAS), were found to be associated with PD in three independent samples, with a two-SNP haplotype associated in each of three samples in the same direction, and with a P-value of 1.2e-7 in the combined sample (909 cases and 915 controls). Independent SNPs in this gene were also associated with the severity of anxiety symptoms in patients affected by PD or panic attacks as well as in patients suffering from unipolar depression. Risk genotypes for PD were associated with higher TMEM132D mRNA expression levels in the frontal cortex. In parallel, using a mouse model of extremes in trait anxiety, we could further show that anxiety-related behavior was positively correlated with Tmem132d mRNA expression in the anterior cingulate cortex, central to the processing of anxiety/fear-related stimuli, and that in this animal model a Tmem132d SNP is associated with anxiety-related behavior in an F2 panel. TMEM132D may thus be an important new candidate gene for PD as well as more generally for anxiety-related behavior